Andrew Walker of BHSI discusses the current claims landscape and what it takes to keep abreast of the risks ahead.

Michael Hennessey talks about joining IMA, the growing cannabis industry and what that means for the commercial insurance industry. 

Danielle Lisenbey made history by becoming the first female member of the Crawford & Co. Global Executive team. This November, she begins a new chapter as president at MedRisk.

Vincent Foderingham details his 23 years in risk, the need for a more diverse workforce and what the industry will look like post-pandemic. 

Though COVID-19 is exacerbating some exposures in the long-term living space, underwriters will be pragmatic as they evaluate the impact on risk profiles.   

While musculoskeletal disorders can be difficult to treat, one of the most effective tools against chronic pain can be found in our brains rather than in a prescription bottle. 

Criminal law professor Deborah Ramirez says it’s time for mandatory professional liability insurance for police officers. Will insurance step up to help?

Laura Langone, the 2020 president of RIMS, discusses the rise of Insurtech, a commitment to learning and why risk professionals need to break into boardrooms.

When all stakeholders understand the direction care will take, it is easier to prevent care delays and avoid harmful treatment missteps.

Andreas Berger, Swiss Re Corporate Solutions’ CEO, details the industry’s challenges and the necessary changes to solve them.

Plotting out steps to recovery at the onset of a claim helps engage injured workers in their treatment and can minimize treatment delays.

Ironshore’s Dave Standish explains some of the top risks associated with collecting biometric data, from liability and the legal landscape to how to protect against a data breach.

Dislocation and marked premium price increases are common in many insurance markets these days. The Hartford’s Adrien Robinson weighs in.

Insurtech continues to bring promise of disruption and innovation to the industry, as one expert expects a transition from big numbers to big data, allowing for a more granular approach to pricing risks.

In the post-#MeToo era, Rhonda Prussack of BHSI details what liability exposures she’s watching closely right now, as well as what underwriters and the courts have their sights set on.

Silvia Sacalis of Healthesystems details the different aspects of holistic care for injured workers and why each is important for a successful return-to-work.

Outgoing NWCDC chairman Roberto Ceniceros chatted with R&I about managing vendor-partners, the power of language and putting technology in perspective.

BHSI’s David Valzania discusses the challenges and opportunities in multinational coverage.

Specialty drugs, prescription cascades and generics are all impacting the cost of drugs in the workers’ compensation industry.

Captive leader Anne Marie Towle sat down to discuss her new role at Hylant, her effective leadership role and the goals for her career at the captive practice.